Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hardaway

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|June 4, 2019
HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA<sup>+</sup> liver metastasesSteven C Katz, John Hardaway, Ethan Prince, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cellsPing Yu, Cara L Haymaker, Rohit D Divekar, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|June 4, 2019
HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA<sup>+</sup> liver metastasesSteven C Katz, John Hardaway, Ethan Prince, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cellsPing Yu, Cara L Haymaker, Rohit D Divekar, et al.
Pageof 1